These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18158122)

  • 1. Dyslipidemia can reduce the immunosuppressive effects of cyclosporine.
    Pozzetto U; Citterio F; Fioravanti G; Navarra P; Boccalini F; Castagneto M
    Transpl Immunol; 2008 Feb; 18(4):349-51. PubMed ID: 18158122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of PPARgamma enhances in vitro the immunosuppressive effect of cyclosporine on T lymphocytes.
    Rampino T; Ranghino A; Guidetti C; Gregorini M; Soccio G; Marasà M; Libetta C; Guida G; De Amici M; Dal Canton A
    Transpl Immunol; 2007 Jul; 18(1):32-6. PubMed ID: 17584600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients.
    Falck P; Asberg A; Guldseth H; Bremer S; Akhlaghi F; Reubsaet JL; Pfeffer P; Hartmann A; Midtvedt K
    Transplantation; 2008 Jan; 85(2):179-84. PubMed ID: 18212621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the sensitivity of pig and human peripheral blood mononuclear cells to the antiproliferative effects of traditional and newer immunosuppressive agents.
    Wright DC; Deol HS; Tuch BE
    Transpl Immunol; 1999 Sep; 7(3):141-7. PubMed ID: 10608297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong additive effect of calcitriol and cyclosporine A on lymphocyte proliferation in vitro and rat liver allotransplantations in vivo.
    Zhang AB; Zheng SS
    Chin Med J (Engl); 2006 Dec; 119(24):2090-5. PubMed ID: 17199961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
    Li J; Xia J; Zhang K; Xu L
    J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the immunosuppressive effects of cyclosporine A and cyclosporine G in vivo and in vitro.
    Rayat G; Yatscoff R; Silverman R; McKenna R
    Transplantation; 1993 Mar; 55(3):623-6. PubMed ID: 8456482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human allograft arterial injury is ameliorated by sirolimus and cyclosporine and correlates with suppression of interferon-gamma.
    Yi T; Cuchara L; Wang Y; Koh KP; Ranjbaran H; Tellides G; Pober JS; Lorber MI
    Transplantation; 2006 Feb; 81(4):559-66. PubMed ID: 16495804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the effects of betamethasone butyrate propionate, vitamin D3 derivatives, and cyclosporine on human lymphocyte-proliferation stimulated with a hemolytic streptococci-derived superantigen.
    Arai K; Uchiyama T; Okubo Y; Tsuboi R; Oka K; Hirano T
    Eur J Pharmacol; 2007 Oct; 571(2-3):222-30. PubMed ID: 17628528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine monitoring in peripheral blood mononuclear cells: feasibility and interest. A prospective study on 20 renal transplant recipients.
    Lepage JM; Lelong-Boulouard V; Lecouf A; Debruyne D; Hurault de Ligny B; Coquerel A
    Transplant Proc; 2007 Dec; 39(10):3109-10. PubMed ID: 18089333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrarenal activation of renin angiotensin system in the development of cyclosporine A induced chronic nephrotoxicity.
    Shang MH; Yuan WJ; Zhang SJ; Fan Y; Zhang Z
    Chin Med J (Engl); 2008 Jun; 121(11):983-8. PubMed ID: 18706245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
    Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine A inhibits lymphocyte migration into ovine peripheral nerve allografts.
    Hare GM; Mackinnon SE; Midha R; Wong PY; Au B; Munro C; Andrade W; Hunter DA; Hay JB
    Microsurgery; 1996; 17(12):697-705. PubMed ID: 9588715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients.
    Ross H; Pflugfelder P; Haddad H; Cantarovich M; White M; Ignaszewski A; Howlett J; Vaillancourt M; Dorent R; Burton JR;
    J Heart Lung Transplant; 2008 Feb; 27(2):197-202. PubMed ID: 18267227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abbreviated AUC monitoring of cyclosporine more adequately identified patients at risk for acute rejection during induction of immunosuppressive therapy after kidney transplantation than recommended C2 concentration values.
    Troncoso P; Ortiz AM; Jara A; Vilches S
    Transplant Proc; 2009; 41(1):127-30. PubMed ID: 19249495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C inhibitor, AEB-071, acts complementarily with cyclosporine to prevent islet rejection in rats.
    Merani S; Pawlick RL; Edgar RL; Toso C; Emamaullee J; Anderson CC; Shapiro AM
    Transplantation; 2009 Jan; 87(1):59-65. PubMed ID: 19136892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
    Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
    Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation by immunosuppressive agents of peripheral blood mononuclear cell responses to influenza A virus.
    Gorse GJ; Kopp WC
    J Lab Clin Med; 1987 Nov; 110(5):592-601. PubMed ID: 2444663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.